Research has revealed that the global female infertility pharmaceutical market will increase to be worth $2.5 billion by the end of the forecast period.
List view / Grid view
Filter the results
Custom manufacturing of specialty chemicals and APIs.
Why has the pharma industry and its talents lost interest in developing new antibiotics?
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.
Whitepaper: A study of the peristaltic life and pumping performance of three TPE tubing products to assess their suitability for continuous bioprocessing
Drug manufacturers are increasingly adopting continuous bioprocessing to manufacture biologics as efficiently as possible. This is being driven by a need to reduce production costs and prices of pharmaceutical products. Furthermore, the FDA has stated its support for the implementation of continuous bioprocessing. A key consequence of continuous bioprocessing is…
The UK Competition and Markets Authority has alleged that Aspen paid two other pharmaceutical companies to ensure they were the only supplier of a drug to the NHS.
The FDA recommends drug manufacturers to use LC-HRMS to test for NDMA in ranitidine products, as high temperatures generate the impurity.
The government has announced new measures to prevent parallel exporting to ease the supply chain, in an effort to reduce medicine shortages.
2 October 2019 | By SUEZ – Ozonia® Ozone Systems
The goal of this webinar is to familiarize companies with the applications and benefits of ozone technology in ultrapure water systems and Ozonia Membrel® electrolytic technology – SUEZ’s ozone product that produces ozone directly from water instead of gaseous air or oxygen.
The impact of new and alternative monitoring technologies on labor costs in the laboratory and in manufacturing can be significant.